Seamless Integration in Gene Therapy Process Development
A contract manufacturer running multiple adeno-associated virus (AAV) programs says early engagement between key stakeholders, proactive risk assessments and platform knowledge is core to the successful delivery of gene therapies. The post Seamless Integration in Gene Therapy Process Development appeared first on GEN - Genetic Engineering and Biotechnology News .
We haven't written up this one. GEN Biotechnology has the full story — the link below goes straight to it.
